Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy (Q44146653)
Jump to navigation
Jump to search
scientific article published in September 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy |
scientific article published in September 2002 |
Statements
1 reference
Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy (English)
1 reference
Ulf de Faire
1 reference
Ole Lederballe-Pedersen
1 reference
Sverre E Kjeldsen
1 reference
Richard B Devereux
1 reference
Suzanne Oparil
1 reference
Stevo Julius
1 reference
Peter Aurup
1 reference
Jonathan Edelman
1 reference
Gareth Beevers
1 reference
Frej Fyhrquist
1 reference
Hans Ibsen
1 reference
Krister Kristianson
1 reference
Lars H Lindholm
1 reference
Markku S Nieminen
1 reference
Per Omvik
1 reference
Steven Snapinn
1 reference
Hans Wedel
1 reference
LIFE (Losartan Intervention for Endpoint Reduction) Study Group
1 reference
1 September 2002
1 reference
1 reference
288
1 reference
12
1 reference
1491-1498
1 reference
Identifiers
1 reference
1 reference